Egypt’s COVID-19 recovery rate reaches 73.1%



Wed, 02 Jun 2021 - 03:16 GMT


Wed, 02 Jun 2021 - 03:16 GMT

CAIRO – 2 June 2021:  The recovery rate from the coronavirus (COVID-19) at Egyptian isolation hospitals has reached 73.1 percent, after the number of people recovering from the virus increased to 192823 cases, according to the Ministry of Health's statement

The Ministry of Health and Population said that according to the recommendations of the World Health Organization issued on May 27, 2020, the disappearance of symptoms for 10 days after infection is an indication of the patient's recovery from the Corona virus.

The ministry stated that the total number of infections that was registered in Egypt thus far is 263606 cases, including 192823 cases that have been cured, and 15136 deaths

Head of the Egyptian Holding Company for Biological Products and Vaccines (VACSERA) Heba Waly said Wednesday that the manufacture of China’s Sinovac vaccine in Egypt will take between 8 to 16 weeks.

““We are racing against time to finish our work, as the manufacturing process will start within the current month” Waly said, adding that by the end of this year, VACSERA aims to produce 40 million doses of the vaccine.

On Saturday, Minister of Health Hala Zayed said that Egypt’s administration gives special interest in locally manufacturing the coronavirus vaccine.

Egypt plans to make Egypt a regional hub for producing the vaccine in Africa after meeting the local needs, as the Egyptian Holding Company for Biological Products and Vaccines (VACSERA) would be the main manufacturer to the Chinese Sinovac in Africa, Zayed said while receiving Chinese experts from Sinovac at VACSERA HQ.

The meeting came in preparation of producing Sinovac vaccine in Egypt, as the first shipment of the raw material used to manufacture China’s Sinovac Covid-19 vaccine arrived in the country on Friday.

The shipment is enough to manufacture two million doses at VACSERA by the end of June.  

Egypt has started its vaccination campaign in January, starting with the medical teams at quarantine hospitals, for being on top of priority groups in terms of vaccination.

Egypt late in January received its first batch of the AstraZeneca vaccine, consisting of 50,000 doses, from India, the country has so far also obtained 650,000 doses of the Chinese Sinopharm vaccine,

AstraZeneca says its vaccine has proven 76 percent efficacy against symptomatic coronavirus and 100 percent efficacy against severe or critical symptoms.




Leave a Comment

Be Social